Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.96 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.96 |
| ▸ | HPGD | P15428 | 3/20 | 0.96 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.96 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.72 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.72 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.72 |
| ▸ | ALB | P02768 | 1/20 | 0.55 |
| ▸ | MMP2 | P08253 | 1/20 | 0.55 |
| ▸ | MYC | P01106 | 1/20 | 0.55 |
| ▸ | TRPA1 | O75762 | 2/20 | 0.53 |
| ▸ | NAPRT | Q6XQN6 | 2/20 | 0.53 |
| ▸ | MEN1 | O00255 | 1/20 | 0.53 |
| ▸ | AKR1B10 | O60218 | 1/20 | 0.53 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.53 |
| ▸ | DHFR | P00374 | 1/20 | 0.53 |
| ▸ | LMNA | P02545 | 1/20 | 0.53 |
| ▸ | MPO | P05164 | 1/20 | 0.53 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.53 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydroxytoluic Acid SCHEMBL8352264 | 0.98 | ALDH1A1 (1.00) | ALDH1A1KDM4EHPGDHSD17B10CYP3A4 | |
| Hydroxytoluic Acid SCHEMBL29499765 | 0.98 | ALDH1A1 (1.00) | ALDH1A1KDM4EHPGDHSD17B10CYP3A4 | |
| Hydroxytoluic Acid SCHEMBL25756 | 0.98 | ALDH1A1 (1.00) | ALDH1A1KDM4EHPGDHSD17B10CYP3A4 | |
| Hydroxytoluic Acid SCHEMBL28037743 | 0.98 | ALDH1A1 (1.00) | ALDH1A1KDM4EHPGDHSD17B10CYP3A4 | |
| Hydroxytoluic Acid SCHEMBL11527547 | 0.96 | ALDH1A1 (0.96) | ALDH1A1KDM4EHPGDHSD17B10CYP3A4 | |
| Hydroxytoluic Acid SCHEMBL31174935 | 0.96 | ALDH1A1 (0.96) | ALDH1A1KDM4EHPGDHSD17B10CYP3A4 | |
| Hydroxytoluic Acid SCHEMBL30538816 | 0.96 | ALDH1A1 (0.96) | ALDH1A1KDM4EHPGDHSD17B10CYP3A4 | |
| Hydroxytoluic Acid SCHEMBL238307 | 0.96 | ALDH1A1 (0.96) | ALDH1A1KDM4EHPGDHSD17B10CYP3A4 | |
| Hydroxytoluic Acid SCHEMBL25338040 | 0.96 | ALDH1A1 (0.96) | ALDH1A1KDM4EHPGDHSD17B10CYP3A4 | |
| Hydroxytoluic Acid SCHEMBL622892 | 0.96 | ALDH1A1 (0.96) | ALDH1A1KDM4EHPGDHSD17B10CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-102961364-A | Sensitive and color-changing anti-acne repairing diaphragm | SHANGHAI BIOTECH CO LTD | 2013-03-13 | — | — | CN | claimed |
| CN-102579387-A | Pharmaceutical compositions comprising an S1P modulator | NOVARTIS AG | 2012-07-18 | — | — | CN | claimed |
| CN-101516345-A | Pharmaceutical compositions comprising S1P modulators | NOVARTIS AG (CH) | 2009-08-26 | — | — | CN | claimed |
| CN-1080118-C | Freeze-dried ondanstetron compositions | GLAXO WELLCOME INC (CA) | 2002-03-06 | — | — | CN | claimed |
| CN-1171741-A | Freeze-dried ondansetron compositions | GLAXO WELLCOME INC (CA) | 1998-01-28 | — | — | CN | claimed |
| US-20230251277-A1 | METHOD FOR DETERMINING THE LEVEL OF VITAMIN D AND METABOLITES THEREOF | ROCHE DIAGNOSTICS OPERATIONS, INC. | 2023-08-10 | — | — | US | disclosed |
| EP-4222502-A1 | A METHOD FOR DETERMINING THE LEVEL OF VITAMIN D AND METABOLITES THEREOF | F. Hoffmann-La Roche AG (CH) | 2023-08-09 | — | — | EP | disclosed |
| CN-203123075-U | Photochromic anti-acne repair membrane sheet | TCI SHANGHAI CO LTD | 2013-08-14 | — | — | CN | disclosed |
| CN-102961364-A | Sensitive and color-changing anti-acne repairing diaphragm | SHANGHAI BIOTECH CO LTD | 2013-03-13 | — | — | CN | disclosed |
| CN-102579387-A | Pharmaceutical compositions comprising an S1P modulator | NOVARTIS AG | 2012-07-18 | — | — | CN | disclosed |
| CN-101516345-A | Pharmaceutical compositions comprising S1P modulators | NOVARTIS AG (CH) | 2009-08-26 | — | — | CN | disclosed |
| CN-100512877-C | Germ-free medicinal compositions | ZENECA LTD (GB) | 2009-07-15 | — | — | CN | disclosed |
| CN-1106192-C | Oil-in-water emulsion containing 2, 6-diisopropyl phenol and ethylenediamine tetraacetate | ZENECA LTD (GB) | 2003-04-23 | — | — | CN | disclosed |
| CN-1080118-C | Freeze-dried ondanstetron compositions | GLAXO WELLCOME INC (CA) | 2002-03-06 | — | — | CN | disclosed |
| CN-1309651-A | Morpholine ethers | GLAXO WELLCOME SA (ES) | 2001-08-22 | — | — | CN | disclosed |
| CN-1058002-C | Method for treatment of mixture of hydroperoxide | SUMITOMO CHEMICAL CO (JP) | 2000-11-01 | — | — | CN | disclosed |
| CN-1235014-A | Use of 1,2-pentanediol in cosmetic or dermatological composition containing aqueous dispersion of film-forming polymer particles, and cosmetic or dermatological composition comprising these constituen | OREAL (FR) | 1999-11-17 | — | — | CN | disclosed |
| CN-1177922-A | Oil-in-water emulsion containing 2, 6-diisopropyl phenol and ethylenediamine tetraacetate | ZENECA LTD (GB) | 1998-04-01 | — | — | CN | disclosed |
| CN-1171741-A | Freeze-dried ondansetron compositions | GLAXO WELLCOME INC (CA) | 1998-01-28 | — | — | CN | disclosed |
| CN-1128754-A | Method for treatment of mixture of hydroperoxide | SUMITOMO CHEMICAL CO (JP) | 1996-08-14 | — | — | CN | disclosed |